This information was published on 2025-10-22T00:12:59 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2589750 (IR 1876809) |
| (220) |
18 Jun 2025
|
| (300) |
US, 21 May 2025, 99195270
|
| (500) |
The mark consists of the word "Crescent," with the smaller word "BIOPHARMA" below it and aligned to the right. A crescent shape formed by dots partially encircles the final letters of each word.
|
| (511) (510) |
Class 5
Pharmaceutical products for the treatment of cancer; biologics in the nature of pharmaceutical preparations for the treatment of cancer; antibodies for medical purposes, namely, for the treatment of cancer. |
| (540) |
|
| (550) | Figurative |
| (730) |
Crescent Biopharma, Inc.
|
Find out more about publications on the About page.